SCHEMBL7410334

SCHEMBL7410334

Nc1cc([N+](=O)[O-])c(N)c(S(=O)(=O)NC(Cc2ccccc2)C2=COCO2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
CYP19A1 P11511 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
CYP2D6 P10635 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
HIF1A Q16665 2/20 0.34
MAPK1 P28482 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 3/20 0.33
GAA P10253 2/20 0.33
VCAM1 P19320 1/20 0.32
KMT2A Q03164 2/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
ALOX12 P18054 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2358970 0.69 POLB (0.52) MAPTKMT2AMEN1
SCHEMBL7410329 0.68 POLB (0.55) ALDH1A1L3MBTL1MAPTGAAKMT2A
SCHEMBL15418724 0.67 KDM4E (0.38) L3MBTL1CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL1403521 0.66 HDAC4 (0.56)
SCHEMBL1402921 0.66 HDAC3 (0.45) ALDH1A1KDM4E
SCHEMBL3160034 0.66 CNR2 (0.61)
SCHEMBL1403328 0.65 HDAC3 (0.43)
SCHEMBL1403219 0.64 CTSL (0.44) ALDH1A1MAPTHPGDLMNAKDM4E
SCHEMBL7366592 0.64 POLB (0.69) ALDH1A1L3MBTL1CYP2C9CYP2C19CYP3A4
Hydrochloric Acid SCHEMBL6865246 0.62 NPC1 (0.31) NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999026932-A1 BY AMIDINO GROUP SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR USE AS ANTICOAGULANTS AXYS PHARMACEUTICALS, INC. (US) 1999-06-03 WO disclosed